Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches
Frontiers in Nutrition · 03.09.2025 · 12
DOI: 10.3389/fnut.2025.1661603 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 03.09.2025. Verfasst von Benson M Hamooya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 377 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Metabolic syndrome (MetS) is a complex condition marked by central obesity, dyslipidemia, hypertension, insulin resistance, oxidative stress, and chronic inflammation. These risk factors significantly raise the risk of cardiovascular disease (CVD) through various mechanisms, leading to a public health challenge. MetS contributes to CVD through cardiometabolic derangements such as endothelial dysfunction, atherosclerosis, oxidative stress, and inflammation. Dyslipidemia, especially elevated triglycerides and reduced high-density lipo-protein (HDL) cholesterol is central to atherosclerosis. Additionally, hypertension and insulin resistance damage blood vessels, a process exacerbated by chronic inflammation and oxidative stress. Thus, managing MetS and its components through lifestyle changes like weight control, dietary improvements, exercise, and smoking cessation is essential for reducing CVD risk. Medications targeting specific risk factors, such as blood sugar, cholesterol, and blood pressure, may also be required. Raising awareness and early screening are crucial to countering MetS’s impact on public health. This review provides a comprehensive overview of the mechanisms by which MetS contributes to CVD and the intricate interplay of factors and molecular pathways linking MetS to CVD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
- Department of Cardiovascular Science and Metabolic Diseases, Livingstone Center for Prevention and Translational Science, Livingstone, Zambia.
- Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, United States.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
- Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN, United States.
Förderung
- National Institutes of Health
Zitieren
APA
Hamooya, B. M., Siame, L., Muchaili, L., Masenga, S. K., & Kirabo, A. (2025). Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1661603
Vancouver
Hamooya BM, Siame L, Muchaili L, Masenga SK, Kirabo A. Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1661603
BibTeX
@article{Hamooya2025,
author = {Hamooya, Benson M and Siame, Lukundo and Muchaili, Lweendo and Masenga, Sepiso K and Kirabo, Annet},
title = {Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1661603}
}
EUVIMED